Skip to Main content Skip to Navigation
Journal articles

QuiPO : qui administre les EPO en prédialyse ?

Abstract : Erythropoiesis Stimulating Agents (ESA) are largely prescribed before dialysis stage to chronic kidney disease patients. In accordance to current international guidelines, lots have been made by pharmacological companies in order to improve self management of ESAs: subcutaneaous administration, pencil devices, mutidose cartridges, low injection volume, very fine needles, once a month injections but none is currently known on the percentage of patients who actually do self administration of ESAs.
Document type :
Journal articles
Complete list of metadatas
Contributor : Cécile Vigneau <>
Submitted on : Monday, January 20, 2020 - 12:20:09 PM
Last modification on : Sunday, January 10, 2021 - 11:45:36 PM



Cécile Vigneau, Sylvie Le Stum, Corinne Isnard-Bagnis, Gabriel Choukroun, Yannick Lemeur, et al.. QuiPO : qui administre les EPO en prédialyse ?. Néphrologie & Thérapeutique, 2014, 10 (7), pp.507-511. ⟨10.1016/j.nephro.2014.06.003⟩. ⟨hal-02445623⟩



Record views